Matthew Cavedon If you blinked, you probably missed it: In the same press conference where he announced a federal takeover of DC policing, President Trump also mentioned that he is…
Investing
-
-
Editor's PickInvesting
Georgia State Election Board: Lyft Shouldn’t Have Given Discounted Rides to Voters
Stephen Richer In recent years, the ride-hailing company Lyft has celebrated Election Day by offering a one-day discount of $10 to all riders who enter an election-themed code (for the November…
-
Jeffrey A. Singer The New York Post recently reported on the tragic deaths, “less than three months apart,” of two Texas friends, ages 21 and 22, who died from overdosing…
-
Jeffrey Miron By now, everyone has heard that, in response to President Trump’s urging, Coca-Cola will soon introduce a version of Coke sweetened with US cane sugar rather than high fructose…
-
Romina Boccia and Ivane Nachkebia I don’t know. It feels like we’re paying into this system that was designed for a completely different world. I mean, it was set up…
-
Jennifer Huddleston The Supreme Court recently ruled that a Texas law that requires age verification to access sexual material harmful to minors was subject to intermediate scrutiny in Free Speech…
-
Editor's PickInvesting
The Price of Pragmatism: How the Court’s Retreat from the Constitution Fueled Mass Incarceration
Mike Fox NYU Law Professor Rachel Barkow has written an extraordinary new book, Justice Abandoned: How the Supreme Court Ignored the Constitution and Enabled Mass Incarceration. It is a damning…
-
David J. Bier Immigrant workers seeking a green card—which denotes legal permanent residence in the United States—now face almost a three-and-a-half-year wait to make it through the government’s regulatory morass.…
-
Jeffrey Miron In November 2020, Oregon voters adopted Measure 109, which legalized the therapeutic use of psilocybin in supervised, licensed facilities. While a significant step away from prohibition, the regulatory…
-
Editor's PickInvesting
Government Should Experiment with Eliminating Patient Barriers, Not with Covering Ozempic
Akiva Malamet, Bautista Vivanco, and Michael F. Cannon The Trump administration is planning to expand Medicare and Medicaid coverage of expensive weight-loss drugs like Ozempic under a five-year experiment, according…